Evaxion A (EVAX) Return on Sales (2024 - 2026)
Evaxion A (EVAX) reported Return on Sales of 0.0% for Q1 2026, up 5.0% on a YoY basis from 0.0% in Q1 2025, and down 19.23% quarter-over-quarter from 0.0% in Q4 2025.
Evaxion A (EVAX) Return on Sales (2024 - 2026) Analysis & Trends
Evaxion A has reported Return on Sales for 3 years, with the latest figure at 0.0% in Q1 2026.
- For the quarter ending Q1 2026, Return on Sales rose 5.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (up 5.0% YoY), and the FY2025 full-year result was 0.01%, up 2.0% from the prior year.
- Return on Sales for Q1 2026 stood at 0.0%, down from 0.0% in the prior quarter.
- The five-year high for Return on Sales was 0.15% in Q1 2024, with the low at 0.43% in Q2 2024.
- Historically, Return on Sales has averaged 0.07% across 3 years, with a median of 0.0% in 2025.
- The largest YoY upside for Return on Sales was 43 bps in 2025 against a maximum downside of 19 bps in 2025.
- Evaxion A's Return on Sales stood at 0.34% in 2024, then soared by 100 bps to 0.0% in 2025, then dropped by 19 bps to 0.0% in 2026.
- The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.01% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | -0.05% |
| Dec 31, 2024 | -0.34% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.43% |
| Mar 31, 2024 | 0.15% |